一本到高清视频不卡dvd,高清一本dvd,一本道av,日本一本二本三区无码

  • <delect id="eyjux"><rp id="eyjux"><td id="eyjux"></td></rp></delect>
  • <acronym id="eyjux"></acronym>
    
    

    <object id="eyjux"><strong id="eyjux"></strong></object>

    www.taishunjiguang.com 提示:

    本信息僅供醫學專業人士參考,如果您是醫學專業人士,請點擊確定后進入。 如果不是,請點擊取消。

    取消 確定

    Products and services

    In 3SBio, meeting the needs of patients is the core of all actions.

    Our global list of drug combinations

    The following is a list of products listed by our company, which is only for medical professionals to refer to.

    YISAIPU (Recombinant human type II tumor necrosis factor receptor - antibody fusion protein)

    YISAIPU was marketed in 2005 and is the first antibody fusion protein medicine marketed in the rheumatism field of China. 3 kinds of indications were approved by the NMPA: Treatment of rheumatoid arthritis (approved in 2005), ankylosing spondylitis and psoriasis (approved in 2007). It is included in the National Medical Insurance Catalogue as a Category B drug of western medicine.

    Indication Manufacturing base Dosage form & Dosage
    Moderate to severe rheumatoid arthritis;
    Moderate to severe plaque psoriasis (PS) in adults aged 18 or above;
    Active ankylosing spondylitis.
    Shanghai manufacturing base 12.5 mg/bottle; 25 mg/bottle
  • <delect id="eyjux"><rp id="eyjux"><td id="eyjux"></td></rp></delect>
  • <acronym id="eyjux"></acronym>
    
    

    <object id="eyjux"><strong id="eyjux"></strong></object>

    一本到高清视频不卡dvd,高清一本dvd,一本道av,日本一本二本三区无码

    品牌简介

    一本到高清视频不卡dvd,高清一本dvd,一本道av,日本一本二本三区无码